A Phase II/III Randomized Study Comparing Efficacy of Nolatrexed to Doxorubicin in Patients with Unresectable HCC
Refereed conference paper presented and published in conference proceedings


Full Text

Other information
All Author(s) ListMok, T., Liu M., Lee S., Chan Y., Leung T., A. Johnston, Johnson P.
Name of ConferenceAbstracts of the NCI-EORTC Symposium on New Drugs in Cancer Therapy
Start Date of Conference19/06/1998
Country/Region of ConferenceNetherlands
Proceedings TitleAbstracts of the NCI-EORTC Symposium on New Drugs in Cancer Therapy
Year1998
Month6
Day19
Issue NumberAbstracts no.664
PublisherNational Cancer Institute
Place of PublicationNetherlands, Amsterdam
LanguagesEnglish-United Kingdom
KeywordsDOXORUBICIN ; HEPATOCELLULAR CARCINOMA ; NOLATREXED

Last updated on 2018-19-01 at 22:45